PMV Pharma
PMVP1.3504.26% ( -0.060 )
PMV Pharma (PMVP)
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other...
- Open
- 1.400
- High
- 1.466
- Low
- 1.315
- Prev. Close
- 1.410
- Volume
- 542.76K
- Turnover
- 741.87K
- Avg Price
- 1.367
- Bid/Ask Ratio
- 33.33%
- Amplitude
- 10.71%
- 52wk High
- 1.910
- Volume Ratio
- 3.48
- Turnover Ratio
- 0.89%
- 52wk Low
- 1.020
- Float Mkt Cap
- 82.54M
- Market CapUSD
- 101.94M
- P/ETTM
- Loss
- P/EDynamic
- Loss
- P/EStatic
- --
- EPSTTM
- -0.996
- EPSDynamic
- -0.957
- EPSStatic
- --
- BVPS
- 0.95
- P/B
- 1.43
- Circulating Supply
- 61.14M
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 75.51M
- Min lot size
- 1
- Currency
- USD
PMV Pharma Analyst Rating
View moreForecast & Rating
Sep 4, 2026Price forecast
$4.20211.11%
Forecast & RatingStrong buy
6analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT ·
PMV Pharma director Matthew Joseph Eckler files initial beneficial ownership statement
- Tip Ranks ·
PMV Pharmaceuticals Adds Veteran Investor to Board
- PUBT ·
PMV Pharma names Samsara BioCapital’s Matt Eckler to board
- rttnews ·
Biotech Stocks At 52-Week Highs - KOD, MASS, OBIO, CDNA, PMVP
- Market Beat ·
PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Receives Consensus Rating of "Moderate Buy" from Brokerages
- TradingView ·
PMV Pharmaceuticals Enters Underwriting Agreement With TD Securities for ~$47 Million Offering
